VINEETLAB36.00

Vineet Laboratories Limited

· Pharma & Health
₹ CrorePeersBIOFILCHEMMANGALAMLASAKREBSBIOALPABALPHARMAORTINGLOBENATCAPSUQMcap ₹69.2 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation-0.02.52.4
+ Finance Costs2.54.04.9
+ Interest Income-0.52.0-0.1
+ Fair Value (Gains) / Losses-0.0-0.00.0
+ Unrealised FX (Gain) / Loss-0.0-0.00.0
Changes in Working Capital
+ Inventories-3.2-0.6-14.1
+ Trade Receivables — Current3.618.41.8
+ Other Financial Assets — Current0.00.7-0.0
+ Other Financial Assets — Non-current-0.10.00.0
+ Other Current Assets-1.53.2-2.8
+ Other Non-current Assets0.1-0.5-0.0
+ Trade Payables — Current-2.61.4-8.3
+ Other Financial Liabilities — Current0.1-0.42.3
+ Other Financial Liabilities — Non-current0.00.00.4
+ Other Current Liabilities-10.01.70.0
+ Provisions — Current0.00.1-0.0
+ Provisions — Non-current0.20.00.0
Cash from Operating Activities
Profit Before Tax (per I/S)0.4-20.81.3
+ Total Adjustments (incl. Working Capital)-11.532.4-13.5
Cash from Operations (pre-tax)-11.211.6-12.2
+ Income Taxes Paid0.30.10.0
Cash from Operating Activities-11.411.5-12.2
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)0.21.01.2
+ Interest Received — Investing0.5-2.00.1
+ Other Inflows / (Outflows) — Investing0.1-0.2-0.0
Cash from Investing Activities0.3-3.2-1.1
Cash from Financing Activities
+ Proceeds from Issue of Shares0.00.030.0
+ Proceeds from Other Equity Instruments0.00.0-0.6
+ Proceeds from Borrowings19.1-3.610.2
+ Repayment of Borrowings5.90.64.9
+ Interest Paid2.54.04.9
Cash from Financing Activities10.7-8.229.7
Net Changes in Cash (pre-FX)-0.40.116.4
Net Changes in Cash-0.40.116.4
Closing Cash0.2
Reference Items
EBITDA7.2-16.38.5
EBITDA Margin %4.78-21.7114.27
Free Cash Flow (CFO − Capex)-11.710.4-13.4
Free Cash Flow to Equity2.2-13.0
Free Cash Flow per Basic Share-6.075.44-7.00
Cash Flow to Net Income-11.13-0.57-7.63
Cash Paid for Taxes0.30.10.0
Cash Paid for Interest2.54.04.9
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.